Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 9, 2020 - Sedor Pharmaceuticals announced the FDA approval of Sesquient (fosphenytoin sodium).
Return to publications